A study to evaluate the efficacy and safety of subcutaneous amlitelimab monotherapy compared with placebo in adult participants with severe alopecia areata

Authors
Category Primary study
Registry of TrialsJapan Primary Registry Network
Year 2024
This article has no abstract
Epistemonikos ID: e28b8e3793cecb9ead4ff2da22f205b2dd22a1ba
First added on: Apr 11, 2025